Phage display research is advancing rapidly. Creative Biolabs supports this momentum with cutting‑edge platforms designed to address emerging challenges in binder discovery and screening.

A research team from Boston University reported the development of a droplet microfluidic component library in a study published in Microsystems & Nanoengineering. The study introduces a rapid and ...

Population screening of asymptomatic persons with Epstein–Barr virus (EBV) DNA or antibodies has improved the diagnosis of nasopharyngeal carcinoma and survival among affected persons. However, the ...